TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome

Hector L Franco1, Anusha Nagari1, W Lee Kraus1

  • 1Laboratory of Signaling and Gene Regulation, Cecil H. and Ida Green Center for Reproductive Biology Sciences and Division of Basic Reproductive Biology Research, Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Molecular Cell
|March 11, 2015
PubMed

Insights

Combined estradiol (E2) and tumor necrosis factor alpha (TNFα) signaling rapidly alters gene expression in breast cancer cells. This crosstalk creates new estrogen receptor alpha (ERα) binding sites, influencing cancer phenotypes and clinical outcomes.

Area of Science:

  • Molecular biology
  • Cancer research
  • Genomics

Background:

  • Mitogenic and proinflammatory pathways significantly impact breast cancer phenotypes and outcomes.
  • Understanding the crosstalk between estradiol (E2) and tumor necrosis factor alpha (TNFα) signaling is crucial for breast cancer research.

Purpose of the Study:

  • To define the immediate transcriptional effects of E2 and TNFα crosstalk in breast cancer cells.
  • To investigate the genomic mechanisms underlying gene expression changes induced by combined E2 + TNFα treatment.

Main Methods:

  • Utilized GRO-seq (Global Run-On sequencing) in MCF-7 breast cancer cells.
  • Analyzed transcriptional responses to individual and combined E2 and TNFα treatments.
  • Investigated enhancer remodeling and transcription factor binding site redistribution (NF-κB, FoxA1).

Main Results:

  • Identified a large set of target genes rapidly altered by combined E2 + TNFα, but not by either agent alone.
  • Demonstrated extensive remodeling of the estrogen receptor alpha (ERα) enhancer landscape dependent on NF-κB and FoxA1.
  • Found that expression of synergistically regulated genes is strongly associated with breast cancer clinical outcomes.

Conclusions:

  • TNFα signaling, through NF-κB and FoxA1, creates latent ERα binding sites, altering gene expression patterns.
  • This crosstalk influences clinically relevant cellular responses in breast cancer.
  • Genomic and molecular analyses reveal a novel mechanism of gene regulation in breast cancer.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
6.4K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.8K
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
13.0K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
76.8K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
6.6K